Stomach Cancer Trial, Recruiting NCT02838836 Sponsor: University of Missouri-Columbia Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT02838836
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be 18 years old or older.
  • People of any gender or ethnic background are welcome.
  • You have been diagnosed with one of the following solid cancers at any stage: lung, esophageal, stomach, bile duct/pancreas, colorectal, melanoma, or sarcoma.
  • You may also be eligible if you have no history of cancer and are having surgery for a non-cancer-related reason (to serve as a comparison participant).
  • If you are having cancer surgery, your cancer should ideally have been confirmed by a tissue sample (biopsy), but you may still qualify if imaging and your doctor's assessment strongly suggest cancer — no extra biopsies or tests will be done just for this study.
  • You must be able to understand and sign a consent form agreeing to take part.

Who may not be able to join:

  • Women who are pregnant cannot participate.
  • If you currently have a second active cancer (other than a common type of minor skin cancer called basal cell carcinoma) and there are signs the cancer is active or you are currently receiving chemotherapy, you will not be eligible.
  • If your blood count (specifically haemoglobin) is below a certain low level on the morning of your procedure, you will not be eligible.
  • If you need a large blood transfusion (more than 4 units of red blood cells) during surgery, no further blood samples for this study will be collected during or the day after your operation.
  • If you have a bleeding or clotting disorder (such as haemophilia or very low platelet counts) that requires preventive treatment before procedures, the bone marrow sampling part of the study will not be performed on you.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jussuf T Kaifi, MD, PhD, Ellis Fischel Cancer Center, University of Missouri

Phone: 5738828445

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Missouri-Columbia
Registry
ClinicalTrials.gov
Start date
1 July 2016
Est. completion
1 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

CTC/DTC numbers measured in blood, urine and bone marrow samples will be correlated with patient outcome

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov